Study Summary
The purpose of this clinical trial is to assess the feasibility, safety and efficacy of anti-GD2/PSMA bi-specific CAR-T cell therapy in patients with GD2 and PSMA positive tumor. Another goal of the study is to learn more about the function of the anti-GD2/PSMA bi-specific CAR-T cells and their persistency in patients.
Want to learn more about this trial?
Request More InfoInterventions
bi-4SCAR GD2/PSMA T cellsBIOLOGICAL
Infusion of bi-4SCAR GD2/PSMA T cells at 10\^6 cells/kg body weight via IV
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Shenzhen Geno-immune Medical Institute | Shenzhen | Guangdong | China |